These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11882128)

  • 1. Long-term illness and patterns of medicine taking: are people with schizophrenia a unique group?
    Marland GR; Cash K
    J Psychiatr Ment Health Nurs; 2001 Jun; 8(3):197-204. PubMed ID: 11882128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of partial compliance.
    Marder SR
    J Clin Psychiatry; 2003; 64 Suppl 16():3-9. PubMed ID: 14680412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies.
    Kane JM
    J Clin Psychiatry; 2003; 64 Suppl 16():34-40. PubMed ID: 14680417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Noncompliance--a typical problem in psychiatric patients. Individual, social and illness-specific factors].
    Hartung HD
    Fortschr Med; 1998 Jan; 116(3):28-30. PubMed ID: 9522542
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicine taking decisions: schizophrenia in comparison to asthma and epilepsy.
    Marland GR; Cash K
    J Psychiatr Ment Health Nurs; 2005 Apr; 12(2):163-72. PubMed ID: 15788033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of barriers to medication adherence in schizophrenia.
    Hudson TJ; Owen RR; Thrush CR; Han X; Pyne JM; Thapa P; Sullivan G
    J Clin Psychiatry; 2004 Feb; 65(2):211-6. PubMed ID: 15003075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Which factors modify drug-compliance?].
    Albus M; Burkes S; Scherer J
    Psychiatr Prax; 1995 Nov; 22(6):228-30. PubMed ID: 8570752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of antipsychotic medication taking in people with schizophrenia.
    McCann TV; Deans C; Clark E; Lu S
    Int J Ment Health Nurs; 2008 Dec; 17(6):428-38. PubMed ID: 19128290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing compliance in schizophrenia patients.
    Fleischhacker WW; Oehl MA; Hummer M
    J Clin Psychiatry; 2003; 64 Suppl 16():10-3. PubMed ID: 14680413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Schizophrenic patient's constant refusal of psychotropic medication--case report and psychodynamic remarks].
    Murawiec S; Zechowski C
    Psychiatr Pol; 2007; 41(4):551-60. PubMed ID: 18046985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-compliance with treatment in patients suffering from schizophrenia: a study to evaluate possible contributing factors.
    Agarwal MR; Sharma VK; Kishore Kumar KV; Lowe D
    Int J Soc Psychiatry; 1998; 44(2):92-106. PubMed ID: 9675629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the treatment worse than the cure? Attitudes toward medications among persons with severe mental illness.
    Van Dongen CJ
    J Psychosoc Nurs Ment Health Serv; 1997 Mar; 35(3):21-5. PubMed ID: 9076705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia.
    Kamali M; Kelly L; Gervin M; Browne S; Larkin C; O'Callaghan E
    Psychiatr Serv; 2001 Feb; 52(2):161-3, 166. PubMed ID: 11157110
    [No Abstract]   [Full Text] [Related]  

  • 14. Research in schizophrenia and the discontinuation of antipsychotic medications.
    Wyatt RJ
    Schizophr Bull; 1997; 23(1):3-9. PubMed ID: 9050108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of treatments that can ameliorate nonadherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2006; 67 Suppl 5():9-14. PubMed ID: 16822091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of maintenance medication for schizophrenia.
    Davis JM; Chen N
    J Clin Psychiatry; 2003; 64 Suppl 16():24-33. PubMed ID: 14680416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of relapse in schizophrenia.
    Weiden PJ; Olfson M
    Schizophr Bull; 1995; 21(3):419-29. PubMed ID: 7481573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders.
    Janssen B; Gaebel W; Haerter M; Komaharadi F; Lindel B; Weinmann S
    Psychopharmacology (Berl); 2006 Aug; 187(2):229-36. PubMed ID: 16710714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.